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Abstract
Background: Premna resinosa (Hochst.) Schauer also called “mukarakara” in Mbeere community of Kenya is used in
the management of respiratory illness. In this study we investigated antituberculous, antifungal, antibacterial activities
including cytotoxicity and phytochemical constituents of this plant.
Methods: Antibacterial and antifungal activities were investigated by disc diffusion and micro dilution techniques.
Antituberculous activity was investigated using BACTEC MGIT 960 system while cytotoxicity was analyzed by MTT assay
on Vero cells (Methanolic crude extract) and HEp-2 cells (fractions). Finally, phytochemicals were profiled using
standard procedures.
Results: P. resinosa had high antituberculous activity with a MIC of <6.25 μg/ml in ethyl acetate fraction. The
antibacterial activity was high and broad spectrum, inhibiting both Gram positive and Gram negative bacteria.
Dichloromethane fraction had the best antibacterial MIC of 31.25 μg/ml against Methicillin-resistant S. aureus
while Ethyl acetate fraction had the highest zone of inhibition of 22.3 ± 0.3 against S. aureus. Its effects on tested fungi
were moderate with petro ether fraction giving an inhibition of 10.3 ± 0.3 on C. albicans. The crude extract and two
fractions (petro ether and methanol) were not within the acceptable toxicity limits, however dichloromethane and
ethyl acetate fractions that exhibited higher activity were within the acceptable toxicity limit (CC50 < 90). The activity
can to some extent be associated to alkaloids, flavonoids, terpenoids, anthraquinones and phenols detected in this
plant extracts.
Conclusion: Our findings demonstrate that P. resinosa has high selective potential as a source of novel lead
for antituberculous, antibacterial and antifungal drugs. Of particular relevance is high activity against MRSA,
S. aureus, C. albicans and MTB which are great public health challenge due to drug resistance development
and as major sources of community and hospital based infections.
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Background
Herbal medicine, also known as practice of herbalism, or
botanical medicine is the use of plants for their thera-
peutic and medicinal values. Historically, all medicines
have an herbal origin with statistics showing that over
80 % of chemical drug compounds originated from nat-
ural material [1]. A survey by UNCTAD has shown that
33 % of drugs produced by industrialized countries are
plant derived while 60 % have a natural origin [2].
Traditional herbal treatment remains the first option
for patients from resource poor countries [3]. World
health organization (WHO) estimates that 80 % of the
world population presently use herbal medicine for some
aspects of their primary health care [4]. This shift to
herbal medication can be attributed to the following fac-
tors: 1. the low cost of herbal drugs endearing them with
the poor mass of developing world; 2. the ‘green’ move-
ment in the developed countries that advocates on the
inherent safety and desirability of natural products; 3.
the individualistic philosophy of western society that en-
courages self-medication, with many people preferring
to treat themselves with phytomedicines [5, 6].
In developing countries like Kenya, there is an increasing
attempt to incorporate traditional medicine in health care
systems [7]. This is after WHO resolution in 2003
(WHA56.31) recommended the inclusion of traditional
healers in management of health care. This move was to
help countries document traditional medicines and remed-
ies in their countries and to ensure their safety and effica-
cies is established [8]. However, it is the duty of scientists
to ensure improvement and scientific justification of herbal
remedies so as to allow their incorporation into health care
systems as an alternative to conventional medicine.
Premna resinosa (Hochst.) Schauer, locally known as
“Mukarakara” in Mbeere community of Embu County in
Kenya, is a shrub, 1.5 - 3 m tall comprising of whitish
branches and stem. The twigs have anti resistance proper-
ties, while roots are used to make perfumes and as medi-
cine for management of respiratory related illnesses [9, 10].
However, to the best of our knowledge, there is no scien-
tific report documented on the antituberculous properties
as well as cytotoxicity properties of this plant. Lack of such
information forms a major limitation in the consideration
of the use of traditional herbal remedies mutually with or
as an affordable alternative to conventional drugs [11]. In
addition, knowledge of phytochemical constituent of plants
is desirable because it can serve in identification of novel
phytocompounds which can be used either in their un-
modified form, as semi-synthetic compounds or as drug
templates. In this study, we sought to interrogate the anti-
microbial activity of water (aqueous) extract, methanol
crude extract and various organic solvents fractions of
root extract from P. resinosa as well as determine
their safety by assaying for their toxicity levels.
Methods
Plant material
The plant for this study was identified through ethno-
botanical approach. The information of its use and prep-
aration in Mbeere community, Kenya was gleaned from
local herbalist and confirmed from documentation by
Relay and Brokensha [9] in The Mbeere in Kenya (ii), Bo-
tanical identity and use. The plant has been used for
management of respiratory related illnesses. This plant
is not an endangered species and it was collected in
open community field and therefore no prior permis-
sion was required. The location for collection was
around 0°46'27.0"S 37°40'54.9"E; −0.774156, 37.681908
of GPS co-ordinates. The identity was also confirmed
by a Botanist at Egerton University where voucher spe-
cimen number NSN11 was deposited and the name
checked as acceptable from [12].
Plant Extract preparation
Root samples were chopped into small pieces of 2–3 cm
and air-dried in dark at room temperature (23 ± 2 °C) to
a constant weight. Using a mechanical grinder, the dried
root specimens were ground to powder. The powder
(50 g) was cold extracted in water with intermittent
shaking to mimic the traditional local method of ex-
traction and later lyophilized to obtain a dry powder.
Another 50 g was macerated in 200 ml of methanol
for 48 h. The extract was then filtered using a filter
paper (whatmann 1) and the residue obtained further re-
extracted using similar amount of methanol. The two
volumes of filtrate were pooled together and there-
after concentrated in vacuo using a rotary evaporator.
Afterwards, the product was allowed to air dry and
the yields recorded.
Fractionation of powdered root part of P. resinosa was
done using different solvents of increasing polarity. The
root powder (50 g) was macerated in 200 ml of Petro
ether with intermittent shaking for 48 h after which they
were filtered using Whatman no 1 filter paper. The resi-
due was further re-extracted using fresh solvent for 24 h
and thereafter the filtrates pooled together. The resulting
residue was air dried and further extracted with Dichlo-
romethane followed by Ethyl acetate and lastly methanol
using the same procedure carried out for Petroleum
ether. Using a rotary evaporator, the solvent was re-
moved from each filtrate under conditions of reduced
temperature and pressure. The resulting dry extract was
weighed and stored in air tight sample bottles at −20 °C
until next use.
Culturing of micro organisms
One Gram positive; Staphylococcus aureus (ATTC
25923) strain and Methicillin Resistant Staphylococcus
aureus strain (clinical isolate), five Gram negative;
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Escherichia coli (ATTC 25922), Klebsiella pneumoniae
(clinical isolate), Pseudomonas aeruginosa (ATCC 27853),
Salmonella typhi (clinical isolate) and Shigella sonnei
(clinical isolate) and two Fungi; Candida albicans (ATTC
90028) and Cryptococcus neoformans (ATTC 66031) were
investigated for antimicrobial activity. The extracts were
also tested against acid fast Mycobacterium tubercu-
losis strain H37Rv (ATCC 27294). These organisms
were sourced from Kenya Medical Research Institute
(KEMRI) - Nairobi.
Disc diffusion test
The antibacterial activity was assayed by disc diffusion
method according to CLSI [13] and Mbaveng et al., [14]
with slight modifications. Fresh inoculum was prepared
by suspending activated colonies in physiological saline
water (0.85 % NaCl). Using 0.5 McFarland turbidity stand-
ard, the bacteria and fungi suspensions were adjusted to
1.5 × 106 CFU/ml after which they were inoculated asep-
tically by swapping the surfaces of the Muller Hinton
(MHA) plates and sabouraud dextrose agar (SDA) plates.
Whatmann filter paper (No.1) discs of 6 mm diameter
were made by punching the paper, and the blank discs
sterilized in the hot air oven at 160 °C for one hour. They
were then impregnated with 10 μl of various stock extract
solution. The methanolic and water crude extracts stock
solution was at (1.0 g/ml). For fractions; petro ether, di-
chloromethane, and methanol fractions stock solutions
were made at 500 μg/ml while ethyl acetate at 250 μg/ml.
This afforded disc extract concentration of 1.0 × 104 μg/
disc for water and methanol crude extracts, 5 μg/disc for
petro ether, dichloromethane, and methanol fractions and
2.5 μg/disc for ethyl acetate. Three standard drugs were
used as positive controls: Oxacillin 10 μg/disc (Oxoid
Ltd, Tokyo-Japan) and Gentamycin 10 μg/disc (Oxoid
Ltd, Tokyo-Japan) for Gram positive and Gram nega-
tive bacteria respectively. Nystatin 100 μg/disc (Oxoid
Ltd, Tokyo-Japan) was used as the standard drug for
all fungi while discs loaded with 10 μl of DMSO was
used as negative controls. The impregnated dry discs
were carefully placed on the agar plates at equidis-
tance points using a sterile forceps. A positive control
as well as a negative control was incorporated in each
plate and the plates incubated at 4 °C for 2 h so as
to allow the extract to diffuse into the media after
which they were incubated at 37 °C for 18 h. Anti-
microbial activity was determined by measuring the
size of the inhibition zone to the nearest mm and the
results recorded. Extracts fractions that gave an inhib-
ition zone of more than 10 mm were considered to
be active [13] and therefore their MIC (Minimum in-
hibitory concentration) and MBC (Minimum bacteri-
cidal concentration) determined [15].
Determination of MIC and MBC
The MIC and MBC of the plant P. resinosa extracts was
determined for all the organisms in triplicates using
broth micro-dilution assay. The petro ether, dichloro-
methane, and methanol fractions stock solutions were
made at 500 μg/ml while ethyl acetate at 250 μg/ml with
DMSO. To 100 μl of nutrient broth agar in a sterile 96
well plate, 50 μl of varying plant concentration (petro
ether, dichloromethane, and methanol fractions at 500
to 3.91 μg/ml while ethyl acetate at 250 to 1.95 μg/m)
was added followed by 50 μl of test organisms previously
diluted to equivalent of 0.5 McFarland standard. Addition
of the test organisms was done in all the wells except for
wells of column 11 which contained neat DMSO and
broth, this served as control to check for purity. The ad-
equacy of the media to support the growth of the test or-
ganism was evaluated by putting the broth and the test
organism in wells of column 12. The plates were then cov-
ered with a sterile “cling-on” sealer and incubated for 24 h
at 37 °C. Bacterial growth was evaluated by addition of
40 μl of 0.2 mg/ml p-iodonitroterazolium chloride (INT,
Sigma) to each well and incubated for 30 min. Growth of
bacteria was detected by formation of a pink-red color-
ation while inhibition of growth was signaled by persist-
ence of a clear coloration. The lowest concentration that
exhibited color change was considered as the MIC.
Minimum bactericidal concentration was determined by
streaking a loopful of broth from wells that exhibited no
color change onto sterile nutrient agar and sabouraud dex-
trose agar for bacteria and fungi respectively and thereafter
incubated at 37 °C for 24 h. The lowest concentration that
exhibited no growth was considered as the MBC [16].
Antitubercular activity
The test organism Mycobacterium tuberculosis H37Rv
ATCC 27294 was sourced from the Kenya Medical Re-
search Institute (KEMRI), Nairobi. Prior to its use, the
Mycobacterium tuberculosis was revived on Lowenstein
Jensen (LJ) slants for 14 days at 37 °C following standard
procedures [17, 18]. The efficacy of the plant extracts
against M. tuberculosis was carried out using the BACTEC
MGIT 960 system (BD, New York-U.S.A). This is a fully
automated, high volume, non-radiometric instrument that
offers continuous monitoring of culture growth. The dry
crude extract (water and methanolic) was first dissolved in
DMSO to a final concentration of 1 g/ml for preliminary
screening. Growth supplement (0.8 ml) containing a mix-
ture of OADC- Oleic Acid, Bovine Albumen, Dextrose
and Catalase was added to five 7 ml BBL™ MGIT™ tube la-
beled GC (growth control), STR (streptomycin), INH (iso-
naizid), RIF (rifampicin), EMB (ethambutol) to provide
essential substrates for rapid growth of Mycobacteria.
100 μl of BBL™ MGIT™ SIRE (streptomycin, isonaizid, ri-
fampicin, ethambutol) prepared aseptically according to
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the manufacturers’ instruction was added to correspond-
ing labeled BBL™ MGIT™ tube followed by addition of
0.5 ml of 1 % Mycobacterium suspension. Mycobacterium
suspension was prepared by pipetting 0.1 ml Middlebrook
7H9 Broth containing Mycobacterium adjusted to 0.5
McFarland standard into 10 ml sterile saline aseptically.
The BACTEC MGIT™ 960 system (BD, New York-U.S.A)
was then loaded following the manufacturer’s instructions
and incubated at 37 °C. Streptomycin at 1.0 μg/ml, isonia-
zid at 0.1 μg/ml, rifampicin at 1.0 μg/ml and ethambutol
at 5.0 μg/ml served as the positive controls whereas
DMSO was used as a negative control. The procedure was
repeated using plant crude extracts at 1.0 g/ml in place of
SIRE. The process was also repeated with petro ether, di-
chloromethane, ethyl acetate and methanol solvent frac-
tions. The fractions were tested at concentrations ranging
from 50 to 6.25 μg/ml (petro ether, dichloromethane and
methanol) or 25 to 3.125 μg/ml (ethyl acetate) to deter-
mine the MIC.
Cytotoxicity screening
MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide] assay was used to determine the toxicity of
the extracts obtained from the plant. This is a colori-
metric assay hinged on the ability of mitochondrial en-
zyme (Succinate Dehydrogenase) to reduce yellow
water soluble MTT to an insoluble colored substance,
formazan, which is spectrophotometrically measurable.
The level of formazan is directly proportional to the
measure of cell viability because only metabolically ac-
tive cells can reduce MTT. Test cell lines were Vero
cells from African green Monkey Kidney cells (Cerco-
pithecus aethiops epithelial cell line; ATCC CCL-81)
against methanol crude extract and HEp-2 cells (human
laryngeal carcinoma cell line ATCC CCL-23) against
fractions that were used as test cells for this study. The
test cells were grown in growth media comprising of
100 ml DMEM, 10 ml Fetal Bovine Serum (FBS), 1 ml
Penstrep, 1 ml Amphotericin B, 1 ml L Glutamine. The
test cells were incubated at 37 °C in 5 % CO2 until they
attained confluency after which they were passaged by
adding 2 ml of 0.25 % trypsin and further incubated at
room temperature until the cell were detached. Growth
media (6 ml) was introduced to the test cells to inacti-
vate trypsin off action, while the cell crumps formed
were broken gently by sucking and releasing the cell
suspension using a pipette. 2 ml of the harvested cells
were then transferred into a 50 ml vial and topped up
to 50 ml mark using growth media. A cell suspension
of 100 μl (1 × 105 cell/ml) was seeded into two rows of
wells A-H in a 96-well micro-titer plate for one sample.
The test cells were then incubated in 100 μl growth media
at 37 °C and 5 % CO2 for 48 h to form a confluent mono-
layer. The growth medium was then aspirated off and
replaced with 100 μl of maintenance medium comprising
of 100 ml DMEM, 2 ml Fetal Bovine Serum (FBS), 1 ml
Penstrep, 1 ml Amphotericin B, 1 ml L-Glutamate and
0.1 ml Gentamycin. Afterwards, cells were exposed to in-
creasing concentrations of respective plant extracts (from
1.95 μg/ml to 500 μg/ml) and incubated at 37 °C for 48 h.
This was followed by a further incubation period of 4 h in
10 μl of 5 mg/ml MTT solution after aspirating off the
plant extracts. This was followed by addition of 100 μl acid-
ified isopropanol (0.04 N HCl in isopropanol). The well
plate was gently shaken for 5 minutes to dissolve the for-
mazan and then optical density measured using ELISA
Scanning Multiwell Spectrophotometer (Multiskan Ex labs-
systems) at 562 nm and 690 nm as reference. Rows of cells
containing medium without plant extracts were included
to act as negative control. Cell viability (%) was calculated
at each concentration as follows using the formula [19].





Phytochemical tests were done to determine the class of
compounds present in the active fractions that could be
responsible for activity and/or cytotoxicity. They were
identified by characteristic colour changes based on
standard procedures as described previously [8, 20–23].
The results were reported as (+) for presence, and (−)
for absence.
Alkaloids
Six to eight drops of Dragendorf reagent was mixed with
2 ml of the extract. Formation of brownish-red precipi-
tate indicated presence of alkaloids. The Dragendorf re-
agent was prepared by mixing two reagents: reagent 1
and reagent 2 in equal parts. Reagent 1 was made by dis-
solving 8.5 g of Bismuth subnitrate in a solution of
10 ml acetic acid and 40 ml of distilled water while as
Reagent 2 was prepared by dissolving 8 g of potassium
iodide in 20 ml of water [22, 23].
Phenols
Phenols were detected using ferric ferichloride which
was prepared by dissolving 0.1 g of ferric ferichloride in
10 ml of water. Equal volumes (2 ml) of both ferric fer-
ichoride and the plant extract were mixed. Formation of
a violet- blue color or greenish color was evidence that
phenols presences [22, 23].
Terpenoids
1 gram of Vanillin was mixed with 100 ml of concen-
trated sulphuric acid after which 2 mls of the resultant
solution was mixed with 2 mls of the plant extract.
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Formation of a blue- green ring or pink- purple color-
ation signified presences of terpenoids [22, 23].
Anthraquinones
0.5 ml of the plant extract was mixed with 0. 5 ml of 10 %
methanolic potasium hydroxide. Red coloration indicated
presences of anthroquinones. 10 % methanolic potassium
hydroxide was prepared by dissolving 0.5 g of potassium
hydroxide pellets in 50 mls of methanol [22, 23].
Flavonoids
5 ml of dilute aqueous ammonia solution was added to a
portion of the aqueous filtrate of the plant extract,
followed by concentrated sulphuric acid. A positive test
result was confirmed by the formation of a yellow color-
ation that disappeared instantly [20, 21].
Statistical analysis
Ms Excel 2010 data sheets and Graphpad Prism version
6 were used to analyze the data. The data on cytotoxicity
was expressed as a percentage of the untreated controls.
CC50 values, which is the concentration that kills 50 %
of the test cells, was determined by Regression Analysis.
A particular fraction’s extract was considered cytotoxic if
it had CC50 of less than 90 μg/ml [24]. In addition, un-
paired student’s t-test was used to test for statistical sig-
nificance in the differences between the treatments and
the control in this study. A p value of less than 0.05 was
considered to indicate statistical significance. Values
were expressed as mean ± S.E.M.
Results and discussion
The information on use and preparation of P. resinosa
plant in Mbeere community-Kenya was gleaned from tra-
dipractitioners and herbalist and confirmed from docu-
mentation by Relay and Brokensha [9]. The plant has
been used traditionally for management of respiratory re-
lated illnesses. Since the traditional preparation involved
steeping the roots peels in water, alcoholic beverage, or
chewing root peels, we first screened for antimicrobial ac-
tivity using water and methanolic crude extract to mimic
this traditional extraction mode. Although herbal practice
in many places as well as in Mbeere community involves
utilization of water as the main herbal extraction solvent,
studies have shown that methanol organic solvent is much
better and potent [5, 25, 26], a fact corroborated by anti-
microbial results of the present study (Tables 1 and 2).
This could be attributed to polarity of methanolic solvent
that confers the ability to extract a variety of bioactive
molecules (Table 3). Polarity of the solvent also influences
the qualitative and quantitative composition of the active
compounds sequestered into herbal extract(s). This could
partly explain the higher activity demonstrated by metha-
nolic crude extract compared to water extract [5, 25–27].
The methanolic crude extract yield was 1 g (Table 4)
and hence we began our antimicrobial screening with a
high concentrations of 1.0 × 104 μg/disc. Both aqueous
and methanol crude extracts had broad spectrum activ-
ity, inhibiting the growth of Gram positive, Gram nega-
tive bacteria and fungi at 1.0 × 104 μg/disc (Table 1).
The highest inhibition in water extract was 11.7 ± 2.0 for
C. albicans while the highest inhibition in methanolic
extract was 11.7 ± 0.3 for S. aureus. The activity against
E. coli and C. albican in both extracts was not statisti-
cally different at p = 0.67 and p = 0.77 respectively. How-
ever methanolic crude extract had higher activity against
S. aureus compared to water crude extract and the dif-
ference in activity between the two extracts was statisti-
cally significant (p = 0.02). Additionally, the positive
control drugs in all cases had higher activity than the
plant crude extract. We also did fractionation using or-
ganic solvents of increasing polarity. Each fraction was
tested on a panel of microorganisms. The results varied
with the extract fraction used for testing. This may sug-
gest that the root part of P. resinosa contains several
antibacterial and antifungal compounds of different po-
larities as supported by phytochemical studies (Table 5).
Fractionation enhanced antibacterial activities in all tested
cases compared to crude methanolic extracts (Table 6).
For example, ethyl acetate fraction had a zone of inhib-
ition of 22.3 ± 0.3 against S. aureus while the crude
Table 1 Antimicrobial activity for the P. resinosa crude root
extract
Extract Diameter of zone of inhibition in mm
Organism
EC SA CA
WT 7.3 ± 1.3 7.0 ± 0.6 11.7 ± 2.0
MOH 8.7 ± 1.3 11.7 ± 0.3 11.0 ± 0
PC 22 ± 0 24.7 ± 1.3 16.3 ± 0.9
NC 0 0 0
WT Water crude extract at 1.0 x 104 μg, MOH Methanol crude extract at 1.0 x
104 μg, EC E. coli, SA S. aureus, CA C. albicans, PC Positive control (Oxacillin
10 μg/disc and Gentamycin 10 μg/disc for Gram positive and Gram negative
bacteria respectively. Nystatin 100 μg/disc for fungi), NC Negative control
(Discs loaded with 10 μl of DMSO), n = 3, Values mean ± SEM
Table 2 Antituberculous activity of P. resinosa crude extract
Sample Solvent GU R/S





WT Water crude extract at 1 g/ml, MOH Methanol crude extract at 1 g/ml, SIRE
Positive control of streptomycin at 1.0 μg/ml, isonaizid at 0.5 μg/ml, rifampicin
at 1.0 μg/ml and ethambutol at 5.0 μg/ml, GC Growth control, NC Negative
control of media treated with DMSO, R Resistant, S Sensitive
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methanolic extract had an inhibition zone of 11.7 ± 0.3 for
the same organism. This may imply that, there is higher
sequestration of active principle(s) at certain level of polar-
ity explaining the high but varied antibacterial activity
demonstrated by fractions from solvents of different polar-
ities. It is also suggestive that, there is possibility of antag-
onism of various antibacterial active compounds when
lumped together as in crude extracts [28], thus explaining
for low antibacterial activity in crude extracts. This is
therefore indicative that, fractions are the best candidates
for the treatment of diseases associated with the tested mi-
croorganisms than crude extracts. Nevertheless, some ex-
tracts fails to have enhanced activity on fractionation as
exhibited by antifungal activity in this study. This may
imply either that, the antifungal principles act together in
a synergistic manner and that is why crude methanolic ex-
tract had higher antifungal activity, or that, fractionation
had dilution effect on the antifungal principle(s) thus
explaining diminished antifungal activity with fraction-
ation (Tables 1 and 6) [28].
The lowest MIC of 31.25 μg/ml was recorded in petro
ether and methanolic fraction against S. aureus. The di-
chloromethane fraction had MIC of 31.25 μg/ml against
methicillin resistant S. aureus (MRSA) and it was also
cidal with MBC of 125 μg/ml. The latter case is more in-
teresting considering that the MIC/MBC ratio is 4
suggesting the killing/cidal effect could be expected
(Table 7). Additionally, out of 20 tested cases for MIC, 8
(40 %) had MIC of less than 100 μg/ml; the set threshold
for plant extract [28]. Generally, activity against Gram
positive bacteria was higher than Gram negative strains
and fungi. This is in agreement with previous studies
that plant extracts are more active against Gram positive
bacteria than Gram negative bacteria. The higher sensi-
tivity of Gram-positive bacteria could be attributed to
their cell wall topology which has outer peptidoglycan
layer which is not an effective permeability barrier as
compared to the outer phospholipid membranes of
Gram-negative bacteria [25, 29, 30]. Difference in sens-
ibility was also evidence among tested strains in both crude
and fraction extracts. This could be due to genetic differ-
ences between different strains. This proofs the necessity
of antibiogram prior to prescription as a precautionary
measure in mitigating drug resistance development [31].
We also investigated the antituberculous activity of crude
extracts and fractions (Tables 2 and 8). Methanolic crude
extract (at 1 g/ml) was highly active in inhibiting tubercle
growth. We went further and investigated activity of or-
ganic solvent fractions with view of determining the MIC.
Interestingly, all fractions had varying level of growth in-
hibition in a concentration dependent manner. The highest
activity was by ethyl acetate fraction (MIC <6.25 μg/ml)
and dichloromethane (MIC <12.5 μg/ml). The MIC for
petro ether fraction was 25.0 μg/ml while that for metha-
nolic fraction was 50.0 μg/ml. This depicts high potential
of the extract fractions (especially ethyl acetate fraction
considering the threshold MIC level of 100 μg/ml [28]) to
be tapped for novel drug lead for management and/or
treatment of TB. This is supported by our data showing
that the level of inhibition by drug standards (SIRE) (GU-
0) is same as that achieved by some of our tests samples
(Table 8). But it is also important to stress that, our frac-
tions were loaded with various bioactive compounds as
shown in Table 5. It is possible that the active compound
could be only a small proportion of the fractions’ extract
and maybe if purified, it could be even of lower amount
than the standard drugs.
Since in some instances people chew the roots of the
plant P. resinosa for herbal treatment, we also sought to
answer the question whether P. resinosa extracts are cyto-
toxic. The methanolic crude extract (CC50 of 1.26 μg/ml),
Petro ether fraction (CC50 of 1.88 μg/ml) and methanolic
fractions (CC50 4.78 μg/ml) were all not within the accept-
able toxicity limit (CC50 > 90.00 μg/ml) (Table 9). This can
Table 3 Phytochemical tests for P. resinosa methanolic crude
extract






V-T Vanillin test for terpenoids, A-F Ammonia test for Flavonoids, MK-A
Methanolic Potassium hydroxide test for Anthraquenones, D-A Dragendorff
test for Alkaloids, F-P Ferric Chloride test for Phenols, − Absent
phytochemicals, + Low concentration of phytochemicals,++ Medium
concentration, +++ High concentration of phytochemicals
Table 4 P. resinosa extracts yield
Yields in grams
Crude extract Fractions
Sample Family MOH WT PE DCM EA MOH
P. resinosar Compositae 1 NR <1 <1 2.531 1
WT Water, MOH Methanol, PE Petro ether, DCM Dichloromethane, EA Ethyl
acetate, MOH Methanol, NR Not recorded
Table 5 Phytochemicals of P. resinosa fractions
Extract fraction V-Ts A-F MK-A D-A F-P
Petro ether - - ++++ +++ -
Dichloromethane ++++ ++++ ++++ ++++ ++++
Ethyl acetate +++ ++++ +++ ++ +++
Methanol ++++ ++++ +++ - ++++
V-T Vanillin test for terpenoids, A-F Ammonia test for Flavonoids, MK-A
Methanolic Potassium hydroxide test for Anthraquenones, D-A Dragendorff
test for Alkaloids, F-P Ferric Chloride test for Phenols, − Absent
phytochemicals, + Low concentration of phytochemicals, ++ Medium
concentration, +++ High concentration of phytochemicals
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however be viewed as “a double edged sword”. In one
way, it is bad for a drug as it will be lethal to subjects.
Nevertheless, structural modification can be undertaken
with view of improving on their safety [19]. On the other
hand, this can be good news since the fractions can be
tapped as candidates for anti-cancerous drugs [5], espe-
cially now that their lethality was toward cancerous hu-
man cell lines.
The observed bioactivity and/or cytotoxicity could be
attributed to the array of phytochemicals that tested
positive in the sample extracts. These included alkaloids,
flavonoids, phenols, terpenoids and anthraquinones. Bio-
active molecules are usually found accumulated as sec-
ondary metabolites in various parts of the plant and at
different concentrations [32]. In this regard, the root is
one of the major depository sites of such compounds
making it a chief part for herbal bioprospecting. Flavo-
noids which tested positive in all samples except in petro
ether fraction have general antibacterial activity. They
have been shown to work by complexing and altering the
conformation(s) of microbial proteins thus inactivating mi-
crobial enzymes and interfering with bacterial cell wall
adhesins. In a similar fashion as terpenoids (also present in
all samples except petro ether fraction), they also mediate
their antibacterial activity through microbial membrane
Table 7 MIC and MBC for the P. resinosa fractions
MIC in μg/ml
Fraction MRSA SA EC SH CA
PE NT 31.25 62.5 NT NT
DCM 31.25 - - NT NT
EA NT 62.5 NT - NT
MOH 125 31.25 62.5 62.5 62.5
MBC in μg/ml
PE NT static static NT NT
DCM 125 static static NT NT
EA NT Static NT static NT
MOH 500 static static static 500
PE Petro ether fraction, DCM Dichloromethane fraction, EA Ethyl acetate
fraction, MOH Methanol fraction, EC E. coli, SA S. aureus, MRSA Methicillin
Resistant S. aureus, SH Shigella, ST S. typhi, CA C. albicans, NT Not tested,
− >500 μg/ml
Table 6 Antimicrobial activity for P. resinosa fractions
Fractions Diameter of zone of inhibition in mm
Microorganism
Gram positive Gram negative Fungi
SA MRSA PA EC KP SH ST CA CR
PE 18 ± 0.6 NT 0 11.3 ± 0.3 0 0 0 10.3 ± 0.3 NT
DCM 19.3 ± 0.3 10.6 ± 0.6 0 10.3 ± 0.3 0 9.7 ± 0.7 0 9.3 ± 0.3 0
EA 22.3 ± 0.3 0 0 0 NT 11.7 ± 0.3 0 6.3 ± 0.3 7.3 ± 0.3
MOH 19.0 ± 0.6 10.7 ± 0.9 0 11.7 ± 0.3 7.3 ± 0.3 12.3 ± 0.3 7.0 ± 0.6 10.0 ± 0.6 NT
PC 33.7 ± 0.3 24.3 ± 0.3 23.7 ± 0.6 17 ± 0.6 15.7 ± 0.3 19.7 ± 0.6 21.3 ± 0.3 16.3 ± 0.3 20.3 ± 0.3
NC 0 0 0 0 0 0 0 0 0
PE Petro ether fraction at 5 μg/disc, DCM Dichloromethane fraction at 5 μg/disc, EA Ethyl acetate fraction at 2.5 μg/disc, MOH Methanol fraction at 5 μg/disc, PA P.
aerogenosa, EC E. coli, SA S. aureus, KP K. pneumoniae, MRSA Methicillin Resistant S. aureus, SH Shigella, ST S. typhi, CA C. albicans, CR Cryptococcus, PC Positive
control (Oxacillin 10 μg/disc and Gentamycin 10 μg/disc for Gram positive and Gram negative bacteria respectively. Nystatin 100 μg/disc for fungi), NC Negative
control (Discs loaded with 10 μl of DMSO), n = 3, values Mean ± SEM
Table 8 Antituberculous activity for P. resinosa fractions
Antituberculous testing
Plant Fraction Concentration μg/ml GU R/S
Premna resinosa
(Hochst.) Schauer




















PE Petro ether fraction, DCM Dichloromethane fraction, EA Ethyl acetate
fraction, MOH Methanol fraction, SIRE Positive control of streptomycin at
1.0 μg/ml, isonaizid at 0.5 μg/ml, rifampicin at 1.0 μg/ml and ethambutol at
5.0 μg/ml, GU Growth unit, NC Negative control of media treated with DMSO,
R Resistant, S Sensitive
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disruption [32]. Other studies have associated flavonoids
with antituberculous activity and it is believed that their
mode of action is by inhibiting various pathways in Myco-
bacteria including de novo biosynthesis of fatty acid, inhi-
biting mycolic acid biosynthesis, proteosome inhibition,
topoisomerase inhibition, inhibition of phosphatidyl-
inositol 3-kinase, induction of cell cycle arrests, accumula-
tion of p53 or enhanced expression of c-fos and c-myc
genes [18, 33]. In addition, recent studies done by [34] in-
dicated that phenolic compounds have antimycobacterial
properties although their mode of action is not well
known. Similarly, studies have established that alkaloids
have both antibacterial and antifungal activities, especially
against S. aureus and C. albicans [35]. The results of this
study provide to some extent scientific rationalization
of the possible therapeutic use of P. resinosa plant in
traditional medicine, and also confirms the impact of eth-
nopharmacological approach when investigating plants for
their bioactivity [31].
Conclusion
A major outcome of the current study is the identifi-
cation of the ethyl acetate and dichloromethane frac-
tions which yielded the best antituberculous activity
(MIC of <12.5 and <6.25 μg/ml respectively) as well as the
highest antibacterial activity (with zones of inhibition of
19.3 ± 0.3 and 22.3 ± 0.3 respectively and the lowest anti-
bacterial MIC of 31.25 μg/ml), all within the acceptable
toxicity limit (CC50 > 90 μg/ml). Our findings also demon-
strates for the first time and to the best of our knowledge
that, P. resinosa plant has very high selective potential as a
source of novel lead for antituberculous, antibacterial and
antifungal drugs. Of particular importance is its high activ-
ity against MRSA, S. aureus, C. albicans and MTB which
are currently posing great public health challenge due to
drug resistance development and as major sources of com-
munity and hospital based infections. Indeed, more work is
needed to identify the specific active ingredients, with a
view of deciphering the mode(s) of action of the plant
compounds. Additionally, the information of cytotoxicity
opens a new frontier to pursue in search of novel antineo-
plastic compounds.
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